Clinical trial · Interventional
Sustained Oral Fiber Supplementation for Patients Undergoing Treatment for Hematological Malignancies
Feasibility of Implementing Sustained Oral Fiber Supplementation for Patients Undergoing Treatment for Hematological Malignancies
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial examines sustained oral fiber supplementation for patients undergoing treatment for hematological malignancies. Patients undergoing cancer treatment, including donor stem cell transplantation often develop oral and gastrointestinal damage from chemotherapy, radiotherapy, or graft-versus-host disease. Oral fiber nutrition support may improve overall nutrition, support a normal gut microbiome (bacteria that live in the gut) and/or improve gut function in patients undergoing treatment for hematological malignancies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic and Lymphatic System Neoplasm | Hematopoietic and Lymphatic System Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (7)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biospecimen Collection | Procedure | — | UNRESOLVED |
| Dietary Supplement | Dietary Supplement | — | UNRESOLVED |
| Electronic Health Record Review | Other | — | UNRESOLVED |
| Fiber and Dietary Assessments | Other | — | UNRESOLVED |
| Kate Farms 1.0 | Dietary Supplement | — | UNRESOLVED |
| Standard of Care Nutritional Support | Dietary Supplement | — | UNRESOLVED |
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Arm I (enteral nutrition) [Discontinued in January 2024]
- description
- Patients receive enteral nutrition via nasoenteric feeding tube starting on day 1 until hospital discharge.
- interventionNames
- Dietary Supplement: Kate Farms 1.0
- Other: Survey Administration
- type
- ACTIVE_COMPARATOR
- label
- Arm II (standard of care) [Discontinued in January 2024]
- description
- Patients receive standard of care nutritional support.
- interventionNames
- Dietary Supplement: Standard of Care Nutritional Support
- Other: Survey Administration
- type
- EXPERIMENTAL
- label
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Able to provide written informed consent prior to initiation of any study procedures * Any diagnosed hematological malignancy * At least 18 years of age * Planned treatment at Fred Hutchinson Cancer Center and/or University of Washington Medical Center Exclusion Criteria: * Major psychiatric diagnosis that impairs cognitive functioning or is not controlled at the time of the approach, as judged by the patient's medical team * Pregnant or breastfeeding. Pregnancy test is obtained as part of pre-transplant evaluation in women of child-bearing potential at arrival to transplant and again within 7 days of conditioning and will be confirmed as negative by review of the chart
References
Publications (0)
Data not yet available